LakeShore Biopharma Co., Ltd. - Ordinary Shares, par value $0.0002 per share (LSBCF)

CUSIP: G9845F208

Q2 2025 13F Holders as of 30 Jun 2025

Type / Class
Equity / Ordinary Shares, par value $0.0002 per share
Shares outstanding
41,218,298
Total 13F shares
323,467
Share change
-1,124,383
Total reported value
$329,684
Price per share
$1.02
Number of holders
7
Value change
-$120,967
Number of buys
2
Number of sells
3

Security key

G9845F208

Report period

Q2 2025

Institutions

7

Top holders

7

LSBCF full security history Ownership snapshot Full 13F holder table Newer quarter: Q3 2025 Previous quarter: Q1 2025 LakeShore Biopharma Co., Ltd. SEC filings LakeShore Biopharma Co., Ltd. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top shareholders of LSBCF - LakeShore Biopharma Co., Ltd. - Ordinary Shares, par value $0.0002 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Lead holder
TORONTO DOMINION BANK
13D/G signal
—
Evidence rows
9
Latest as of
31 Mar 2025
13F Lead comparable stake: 2.5% Showing first 8 of 9 holder rows. Open remaining rows
Holder Evidence Ownership % Position 12M Net Δ As of
TORONTO DOMINION BANK
13F
Company
13F
2.5%
$42,981
1,048,320 shares
 — 31 Mar 2025
ORBIMED ADVISORS LLC
13F
Company
13F
0.34%
$344,049
140,428 shares
 — 31 Mar 2025
FMR LLC
13F
Company
13F
0.28%
$281,949
116,508 shares
 — 31 Mar 2025
HHLR ADVISORS, LTD.
13F
Company
13F
0.18%
$181,933
75,179 shares
 — 31 Mar 2025
SUPERSTRING CAPITAL MANAGEMENT LP
13F
Company
13F
0.07%
$74,517
30,792 shares
 — 31 Mar 2025
BARCLAYS PLC
13F
Company
13F
0.06%
$60,655
24,757 shares
 — 31 Mar 2025
CITADEL ADVISORS LLC
13F
Company
13F
0.03%
$25,618
10,586 shares
 — 31 Mar 2025
UBS Group AG
13F
Company
13F
0%
$2,450
1,000 shares
 — 31 Mar 2025
Show 1 additional holder rows in the full holder list
Holder Evidence Ownership % Position 12M Net Δ As of
Tower Research Capital LLC (TRC)
13F
Company
13F
0%
$686
280 shares
 — 31 Mar 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
7
Shares
323,467
Rows loaded
7
Investor Option Weight % Change % Reported value * Price Shares Share Change Activity Report Period

* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. An asterisk next to the price means the price is likely invalid.

Compare Q2 2025 vs Q1 2025 Across Filers

Q1 2025 holders
9
Q2 2025 holders
7
Holder diff
-2
Investor Q1 2025 Shares Q2 2025 Shares Share Diff Share Chg % Q1 2025 value Q2 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .